Patents by Inventor Lin Wang
Lin Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20120069859Abstract: An all-fiber Q-switched laser including a laser resonant cavity and a loop optical system is provided. The loop optical system is disposed inside the laser resonant cavity, and the all-fiber Q-switched laser generates a pulsed laser through the loop optical system. The loop optical system includes a plurality of wavelength-division elements and a saturable absorber. One of the wavelength-division elements is coupled with another one of the wavelength-division elements through corresponding first connecting fibers. Two ends of the saturable absorber are respectively coupled to second connecting fibers of the wavelength-division elements, wherein the saturable absorber and the two wavelength-division elements form a loop such that an auxiliary unsaturated light source can be transmitted in the loop.Type: ApplicationFiled: December 8, 2010Publication date: March 22, 2012Applicant: lINDUSTRIAL TECHNOLOGY RESEARCH INSTITUTEInventors: Shih-Ting Lin, Tzong-Yow Tsai, Hong-Xi Cao, Chih-Lin Wang
-
Patent number: 8138781Abstract: A test circuit adapted in a display panel of an electronic device is provided. The test circuit is to test the pixel array function of the display panel, wherein the test circuit comprises: a plurality of test signal lines, a plurality of test signal transmitters, a plurality of gate lines and at least one static electricity protection device. The test signal lines receive a plurality of corresponding test signals respectively. The test signal transmitters comprises a plurality test signal transmitter groups comprising at least one transmitter, wherein each transmitter group corresponds to a test signal line and connects the test signal line and the to pixel array. Each gate line connects to the gate of the at least one transmitter. The static electricity protection device is placed between two of the gate lines.Type: GrantFiled: December 31, 2008Date of Patent: March 20, 2012Assignees: AU Optronics (Suzhou) Corp., Ltd., AU Optronics CorporationInventors: Xiao-Lin Wang, Ting-Ting Liu, Jie Xi
-
Publication number: 20120061259Abstract: A biosensor for quantifying an analyte in a sample and usage thereof are provided. The biosensor includes an insulative substrate, a cover, a sample supply port, an electrode system including at least a working electrode, a counter electrode and a third electrode, and a reaction layer at least formed over the working electrode. The third electrode, used for estimating whether the amount of the sample is sufficient, is disposed nearer to the sample supply port than the counter electrode is. Whether the amount of the added sample is sufficient is estimated by comparing the electrical current value detected between the working electrode and the counter electrode with the electrical current value detected between the working electrode and the third electrode. This invention has a simple structure and produces accurate measurements.Type: ApplicationFiled: May 24, 2010Publication date: March 15, 2012Applicant: LEADWAY (HK) LIMITEDInventors: Jinn-Nan Lin, Chia-Lin Wang, Ziyi Zhang
-
Patent number: 8133992Abstract: Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.Type: GrantFiled: January 29, 2009Date of Patent: March 13, 2012Assignee: Exelixis, Inc.Inventors: Richard Martin, Tie-Lin Wang, Brenton T. Flatt, Xiao-Hui Gu, Ronald Griffith
-
Publication number: 20120058488Abstract: Embodiments of the present Invention provide antibody functionalized high electron mobility transistor (HEMT) devices for marine or freshwater pathogen sensing. In one embodiment, the marine pathogen can be Perkinsus marinus. A sensing unit can include a wireless transmitter fabricated on the HEMT. The sensing unit allows testing in areas without direct access to electrical outlets and can send the testing results to a central location using the wireless transmitter. According to embodiments, results of testing can be achieved within seconds.Type: ApplicationFiled: May 6, 2010Publication date: March 8, 2012Applicant: University of Florida Research Foundation Inc.Inventors: Barbara Jane Sheppard, Yu-Lin Wang, Fan Ren, Stephen John Pearton
-
Patent number: 8125787Abstract: The frame assembly mainly contains a number of linear edge members and a number of L-shaped corner members end-to-end joining the edge members by a number of connection pieces into a rectangular frame surrounding a touch panel. Both the edge and corner members have a C-shaped cross section with a space inside for holding circuit boards of the touch panel. The circuit boards of the corner and edge members are aligned so that their connectivity by matching connectors is easily established when putting the frame assembly together.Type: GrantFiled: April 17, 2008Date of Patent: February 28, 2012Assignee: ET&T Technology Co., Ltd.Inventors: Jung-Yu Chen, Chien-Ping Sun, Yi-Te Chien, Wei-Lin Wang
-
TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY
Publication number: 20120040985Abstract: The present invention comprises TGR5 agonists of structural formula I, wherein X, R1, R2, and R5 are defined herein, as well as N-oxides of them and pharmaceutically acceptable salts thereof. The invention further comprises composition comprising the compounds, N-oxides, and/or pharmaceutically acceptable salts thereof. The invention also comprises use of the compounds and compositions for treating diseases in which TGR5 is a mediator or is implicated. The invention also comprises use of the compounds in and for the manufacture of medicaments, particularly for treating diseases in which TGR5 is a mediator or is implicated.Type: ApplicationFiled: February 12, 2010Publication date: February 16, 2012Applicant: EXELIXIS PATENT COMPANY LLCInventors: Venkataiah Bollu, Brant Clayton Boren, Jackaline Dalgard Julien, Brenton T. Flatt, Nadia Haq, Sarah Hudson, Raju Mohan, Michael Morrissey, Benjamin Pratt, Tie-Lin Wang, Richard Martin, Xiao-Hui Gu -
Publication number: 20120036560Abstract: The present invention relates to methods, apparatuses, and computer program products for providing secure access for a user or terminal to a network, wherein an intermediate authentication node is authorized to listen to and store authentication related information. When an authentication request is received, the stored authentication related information is checked and the user or terminal is authenticated if a match between authentication related information of the authentication request and the stored authentication related information is determined, and an authentication server responsible for the authentication request is notified about the authentication result.Type: ApplicationFiled: May 5, 2009Publication date: February 9, 2012Applicant: NOKIA SIEMENS NETWORKS OYInventors: Xing Lin Wang, Lei Li, Xue Gang Huang
-
Patent number: 8093838Abstract: In a driving circuit and method for preventing a lamp from blasting, a driving circuit includes a control circuit module, a voltage conversion circuit module, a driving module and a feedback circuit. The control circuit module outputs a first control signal according to a predetermined setting. The voltage conversion circuit module receives the first control signal and converts the first control signal into a second control signal. The driving module receives the second control signal and generates a driving signal according to the second control signal for driving the lamp. The feedback circuit electrically couples to one of the control circuit module, the voltage conversion circuit module and the driving module for receiving a feedback signal therefrom. The feedback signal is transmitted to the control circuit module, so that the control circuit module may adjust the first control signal according to the feedback signal.Type: GrantFiled: October 23, 2008Date of Patent: January 10, 2012Assignee: Coretronic CorporationInventors: Chih-Lin Wang, Po-Yen Wu
-
Publication number: 20110301128Abstract: Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.Type: ApplicationFiled: August 22, 2011Publication date: December 8, 2011Applicant: EXELIXIS, INC.Inventors: Lynne Canne Bannen, Jeff Chen, Lisa Esther Dalrymple, Brenton T. Flatt, Timothy Patrick Forsyth, Xiao-Hui Gu, Morrison B. Mac, Larry W. Mann, Grace Mann, Richard Martin, Raju Mohan, Brett Murphy, Michael Charles Nyman, William C. Stevens, Tie-Lin Wang, Yong Wang, Jason H. Wu
-
Publication number: 20110293820Abstract: Metal-polymer composites, and methods of making and use thereof, said composites comprising a thermally-cured dense polyaniline substrate; an acid dopant; and, metal nanostructure deposits wherein the deposits have a morphology dependent upon the acid dopant.Type: ApplicationFiled: August 2, 2011Publication date: December 1, 2011Applicant: Los Alamos National Security, LLCInventors: Hsing-Lin Wang, Sea Ho Jeon, Nathan H. Mack
-
Publication number: 20110263544Abstract: The present invention comprises a compound for the prevention and/or treatment of cardiovascular diseases, nephropathy, fibrosis, primary aldosteronism or edema. The compound is of the following general formula (I): wherein R1 represents a C1-C3 alkyl group; R2 represents a hydroxy-C1-C4 alkyl group and the like; R3 represents a halogeno group, a halogeno-C1-C3 alkyl group and the like; R4 represents a hydrogen atom, a halogeno group and the like, —R5 represents a sulfamoyl group or a C1-C3 alkylsulfonyl group; R6 represents a hydrogen atom, a halogeno group and the like] or an N-oxide, atropisomer of the foregoing, or pharmaceutically acceptable salt of the foregoing.Type: ApplicationFiled: October 7, 2009Publication date: October 27, 2011Applicants: DAIICHI SANKYO COMPANY, LIMITED, EXELIXIS, INC.Inventors: John Nuss, Matthew Williams, Raju Mohan, Richard Martin, Tie-Lin Wang, Hiroyuki Tsuruoka, Kazumasa Aoki, Masatoshi Honzumi, Yusuke Asoh, Keiji Saito, Tsuyoshi Homma
-
Publication number: 20110263673Abstract: The present invention comprises a compound for the prevention and/or treatment of cardiovascular diseases. The compound is an atropisomer of a compound represented by the following general formula (I): wherein R1 represents a C1-C3 alkyl group; R2 represents a 2-hydroxy-C4-C6 alkyl group; R3 represents a halogeno group, a halogeno-C1-C3 alkyl group and the like; R4 represents a hydrogen atom, a halogeno group and the like; R5 represents a C1-C3 alkyl group; and R6 represents a hydrogen atom, a halogeno group and the like] or atropisomers thereof.Type: ApplicationFiled: October 7, 2009Publication date: October 27, 2011Applicants: DAIICHI SANKYO COMPANY, LIMITED, EXELIXIS, INC.Inventors: John Nuss, Matthew Williams, Raju Mohan, Richard Martin, Tie-Lin Wang, Kazumasa Aoki, Hiroyuki Tsuruoka, Noriyuki Hayashi, Tsuyoshi Homma
-
Publication number: 20110239128Abstract: The present invention relates to a data transmission method and system. The system includes a connection module for setting up a transmission path between a computer end and a device end, a display unit, a capture unit disposed at the device end for capturing an image of the screen including an icon, and a computing unit for recognizing the image to determine that the icon corresponding to an object is shown on the image. The method includes the steps of: displaying a screen including an icon at the computer end; capturing an image including an icon of the screen; recognizing the image to determine that the icon corresponding to an object is shown on the image; and transmitting the object from the computer end to the device end through the transmission path. The present invention does not require complicated operation at the computer end and improves convenience for the application.Type: ApplicationFiled: March 23, 2011Publication date: September 29, 2011Applicants: INVENTEC APPLIANCES (SHANGHAI) CO. LTD., INVENTEC APPLIANCES CORP.Inventors: YU-LIN WANG, WEI-HUNG CHEN
-
Patent number: 8026237Abstract: Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.Type: GrantFiled: July 30, 2005Date of Patent: September 27, 2011Assignee: Exelixis, Inc.Inventors: Lynne Canne Bannen, Jeff Chen, Lisa Esther Dalrymple, Brenton T Flatt, Timothy Patrick Forsyth, Xiao-Hui Gu, Morrison B Mac, Larry W Mann, Grace Mann, Richard Martin, Raju Mohan, Brett Murphy, Michael Charles Nyman, William C Stevens, Tie-Lin Wang, Yong Wang, Jason H Wu
-
Patent number: 8025411Abstract: A liquid crystal panel includes a liquid crystal display element, a micro-lens array, an adjustable lens array, and a lens control unit electrically connected to the adjustable lens array. The liquid crystal display element has a light input surface and a light output surface opposite to the light input surface. The micro-lens array has a plurality of micro-lenses disposed on the light input surface of the liquid crystal display element). The adjustable lens array has a plurality of adjustable lenses disposed on the light output surface of the liquid crystal display element. The lens control unit is capable of controlling focal lengths of the plurality of adjustable lenses.Type: GrantFiled: April 28, 2008Date of Patent: September 27, 2011Assignee: Hon Hai Precision Industry Co., Ltd.Inventors: Chien-Wen Hsu, Po-Lin Wang, Ching-Te Chu, Yu-Shan Chou
-
Patent number: 8022152Abstract: Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other uses.Type: GrantFiled: December 19, 2007Date of Patent: September 20, 2011Assignee: E.I. du Pont de Nemours and CompanyInventors: Steven Dale Ittel, Lynda Kaye Johnson, Lin Wang, Ying Wang, Elizabeth Forrester McCord, Catherine E. Radzewich, Stephan James McLain, Karl Jeffrey Sweetman, Alison Margaret Anne Bennett, Alex Sergey Ionkin, Rinaldo Soria Schiffino
-
Patent number: 8004913Abstract: An integrated circuit memory includes multiple memory banks grouped into repair groups Group0, Group1. One memory has redundant rows which can be used to substitute for a defective row found within any of the memory banks within the common repair group concerned. Redundant columns of memory cells may be substituted for defective columns by multiplexing circuitry. This multiplexing circuitry shifts the bit lines selected to form part of a bit group to access a given data bit by an amount less than the multiplexing width being supported by that multiplexing circuitry thereby reducing the number of redundant columns which need be provided.Type: GrantFiled: May 20, 2010Date of Patent: August 23, 2011Assignee: ARM LimitedInventors: Hemangi Umakant Gajjewar, Karl Lin Wang
-
Patent number: 7998995Abstract: Compounds of the invention are disclosed, such as compounds of formulae LX-LXIV, and pharmaceutically acceptable salts, isomers, or prodrugs thereof, which are useful as modulators of the activity of liver X receptors (LXR) and Farnesoid X receptors (FXR), where R00, R200, R400, R500, J11, J21, G1, G21, and Q are defined herein. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.Type: GrantFiled: December 7, 2007Date of Patent: August 16, 2011Assignee: Exelixis Patent Company LLCInventors: Brant Clayton Boren, Brett B. Busch, Xiao-Hui Gu, Vasu Jammalamadaka, Shao Po Lu, Richard Martin, Raju Mohan, Edwin Schweiger, William C. Stevens, Tie-Lin Wang, Yinong Xie, Wei Xu
-
Patent number: 7998895Abstract: Transition metal complexes of selected monoanionic phosphine ligands, which also contain a selected Group 15 or 16 (IUPAC) element and which are coordinated to a Group 3 to 11 (IUPAC) transition metal or a lanthanide metal, are polymerization catalysts for the (co)polymerization of olefins such as ethylene and ?-olefins, and the copolymerization of such olefins with polar group-containing olefins. These and other nickel complexes of neutral and monoanionic bidentate ligands copolymerize ethylene and polar comonomers, especially acrylates, at relatively high ethylene pressures and surprisingly high temperatures, and give good incorporation of the polar comonomers and good polymer productivity. These copolymers are often unique structures, which are described.Type: GrantFiled: August 1, 2008Date of Patent: August 16, 2011Assignee: E.I. du Pont de Nemours and CompanyInventors: Lin Wang, Elisabeth M. Hauptman, Lynda Kaye Johnson, Elizabeth Forrester McCord, Stephan J. McLain, Ying Wang